Baird’s Meridian Bioscience VIVO Stock Holding History
Bought
Maintained
Sold
Other funds holding VIVO
CPCM
Baird's VIVO Position: Q1 2015 in Review
Baird sold out of Meridian Bioscience (VIVO) in Q1 2015, closing a stake of 23,252 shares — an estimated $383K sold.
Baird first reported a position in VIVO in Q4 2013 and held it in 5 quarters. The position peaked at $1.62M in Q2 2014. 159 funds tracked by Wall St. Rank hold VIVO as of Q1 2015.
- Baird reported no remaining Meridian Bioscience position as of Q1 2015 after selling out during the quarter.
- Baird sold 23,252 Meridian Bioscience shares in Q1 2015, an estimated $383K.
- Baird first reported a position in Meridian Bioscience in Q4 2013 and held it in 5 quarters.
- Baird's Meridian Bioscience position peaked at $1.62M in Q2 2014.
- 159 funds tracked by Wall St. Rank held Meridian Bioscience as of Q1 2015.
Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.